Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.
A Clinical Predictive Model for One-year Colectomy in Adults Hospitalized for Severe Ulcerative Colitis.
American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities.
Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.
Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate. Am J Gastroenterol. 2020 08; 115(8):1298.
View in:
PubMed
subject areas
Aged, 80 and over
Anemia
Antidiarrheals
Betacoronavirus
Bismuth
Blood Sedimentation
Coronavirus Infections
Cough
C-Reactive Protein
Crohn Disease
Diarrhea
Humans
Lymphopenia
Male
Organometallic Compounds
Pandemics
Pneumonia, Viral
Salicylates
Treatment Outcome
authors with profiles
David Rubin